Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1992 May;83(5):515–521. doi: 10.1111/j.1349-7006.1992.tb01958.x

Mouse‐Human Chimeric Antibody MH171 against the Multidrug Transporter P‐Glycoprotein

Keiko Ariyoshi 1,2, Hirofumi Hamada 1, Mikihiko Naito 3, Yuji Heike 1, Hiroyuki Seimiya 3, Kayoko Maezawa 1,✉, Takashi Tsuruo 1,3
PMCID: PMC5918864  PMID: 1352281

Abstract

We have developed a mouse‐human chimeric antibody MH171, in which the antigen‐recognizing variable regions of the mouse monoclonal antibody MRK17 are joined with the constant regions of human IgG1 antibodies. The MRK17 recognizes specifically the multidrug transporter P‐glycoprotein and inhibits the growth of human multidrug resistant (MDR) tumor cells in vitro and in the xenograft nude mouse model system. The established chimeric MH171 antibody forms an apparently intact IgG composed of heavy and light chains covalently assembled via disulfide bonds in sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis and is specific to MDR cell lines with a similar affinity to the original mouse MRK17. MH171 also displays strong antibody‐dependent cell‐mediated cytotoxicity to the target cells in vitro, when human mononuclear cells are used as effector cells. The chimeric antibody against P‐glycoprotein, MH171, should be a useful agent in the treatment of human drug‐resistant tumors.

Keywords: Key words, Mouse‐human chimeric antibody, P‐glycoprotein, Multidrug‐resistance, MRK17 — MH171

Full Text

The Full Text of this article is available as a PDF (435.2 KB).

REFERENCES

  • 1. ) Riordan , J. R. and Ling , V.Genetic and biochemical characterization of multidrug resistance . Pharmacol. Ther. , 28 , 51 – 75 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Tsuruo , T.Mechanisms of multidrug resistance and implications for therapy . Jpn. J. Cancer Res. , 79 , 285 – 296 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Roninson , I. B. “ Molecular and Cellular Biology of Multi‐drug Resistance in Tumor Cells ” ( 1991. ). Plenum Publishing Corp. , New York . [Google Scholar]
  • 4. ) Safa , A. R. , Glover , C. J. , Meyers , M. B. , Biedler , J. L. and Felsted , R. L.Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug‐resistant cells . J. Biol. Chem. , 261 , 6137 – 6140 ( 1986. ). [PubMed] [Google Scholar]
  • 5. ) Cornwell , M. M. , Safa , A. R. , Felsted , R. L. , Gottesman , M. M. and Pastan , I.Membrane vesicles from multidrug‐resistant human cancer cells contain a specific 150‐ to 170‐kDa protein detected by photoaffinity labeling . Proc. Natl Acad. Sci. USA , 83 , 3847 – 3850 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Hamada , H. and Tsuruo , T.Purification of the 170‐ to 180‐kilodalton membrane glycoprotein associated with multidrug resistance: 170– to 180–kilodalton membrane glycoprotein is an ATPase . J. Biol Chem. , 263 , 1454 – 1458 ( 1988. ). [PubMed] [Google Scholar]
  • 7. ) Hamada , H. and Tsuruo , T.Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P‐glycoprotein) associated with multidrug resistance in K562/ADM cells . Cancer Res. , 48 , 4926 – 4932 ( 1988. ). [PubMed] [Google Scholar]
  • 8. ) Willingham , M. C. , Richert , N. D. , Cornwell , M. M. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. and Pastan , I.Immunocytochemical localization of P170 at the plasma membrane of multidrug‐resistant human cells . J. Histochem. Cytochem. , 35 , 1451 – 1456 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Sugawara , I. , Kataoka , I. , Morishita , Y. , Hamada , H. , Tsuruo , T. , Itoyama , S. and Mori , S.Tissue distribution of P‐glycoprotein encoded by a multidrug‐resistant gene as revealed by a monoclonal antibody, MRK16 . Cancer Res. , 48 , 1926 – 1929 ( 1988. ). [PubMed] [Google Scholar]
  • 10. ) Shen , D‐W. , Fojo , A. , Roninson , I. B. , Chin , J. E. , Sofner , R. , Pastan , I. and Gottesman , M. M.Multidrug resistance of DNA‐mediated transformants is linked to transfer of the human mdrl gene . Mol. Cell. Biol. , 6 , 4039 – 4045 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Gros , P. , Neriah , Y. B. , Croop , J. M. and Housman , D. E.Isolation and expression of a complementary DNA that confers multidrug resistant . Nature , 323 , 728 – 731 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Ueda , K. , Cardarelli , C. , Gottesman , M. M. , and Pastan , I.Expression of a full‐length cDNA for the human “MDR1” gene confers resistant to colchicines, doxorubicin, and vinblastine . Proc. Natl. Acad. Sci. USA , 84 , 3004 – 3008 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. ) Bell , D. R. , Gerlach , J. H. , Kartner , N. , Buich , R. N. and Ling , V.Detection of P‐glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance . J. Clin. Oncol. , 3 , 311 – 315 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Fojo , A. T. , Ueda , K. , Slamon , D. J. , Poplack , D. G. , Gottesman , M. M. and Pastan , I.Expression of a multi‐drug‐resistance gene in human tumors and tissues . Proc. Natl. Acad. Sci. USA , 84 , 265 – 269 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Tsuruo , T. , Sugimoto , Y. , Hamada , H. , Roninson , I. , Okumura , M. , Adachi , K. , Morishima , Y. and Ohno , R.Detection of multidrug resistance markers, P‐glycoprotein and mdrl mRNA, in human leukemia cells . Jpn. J. Cancer Res. , 78 , 1415 – 1419 ( 1987. ). [PubMed] [Google Scholar]
  • 16. ) Hamada , H. , and Tsuruo , T.Functional role for the 170‐ to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. ) Tsuruo , T. , Hamada , H. , Sato , S. and Heike , Y.Inhibition of multidrug‐resistant human tumor growth in athymic mice by anti‐P‐glycoprotein monoclonal antibodies . Jpn. J. Cancer Res. , 80 , 627 – 631 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Meeker , T. C. , Lowder , J. , Maloney , D. G. , Miller , R. A. , Thielemans , K. , Warnke , R. and Levy , R.A clinical trial of antiidiotype therapy for B cell malignancy . Blood , 65 , 1349 – 1363 ( 1985. ). [PubMed] [Google Scholar]
  • 19. ) Miller , R. A. , Lowder , J. , Meeker , T. C. , Brown , S. and Levy , R.Anti‐idiotypes in B‐cell tumor therapy . Natl. Cancer Inst. Monogr. , 3 , 131 – 134 ( 1987. ). [PubMed] [Google Scholar]
  • 20. ) Hamada , H. , Miura , K. , Ariyoshi , K. , Heike , Y. , Sato , S. , Kameyama , K. , Kurosawa , Y. and Tsuruo , T.Mouse‐human chimeric antibody against the multidrug transporter P‐glycoprotein . Cancer Res. , 50 , 3167 – 3171 ( 1990. ). [PubMed] [Google Scholar]
  • 21. ) Marx , J. L.Antibodies made to order: chimeric antibodies — which are part mouse and part human — may help solve the problems hindering the therapeutic use of monoclonal antibodies . Science , 229 , 455 – 456 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Morrison , S. L. and Oi , V. T.Genetically engineered antibody molecules . Adv. Immunol. , 44 , 65 – 92 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Short , J. M. , Fernandez , J. M. , Sorge , J. A. and Huse , W. D.λZAP: a bacteriophage A expression vector with in vivo excision properties . Nucleic Acids Res. , 16 , 7583 – 7600 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Frischauf , A‐M. , Lehrach , H. , Poustka , A. and Murray , N.Lambda replacement vectors carrying polylinker sequences . J. Mol. Biol. , 170 , 827 – 842 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Kameyama , K. , Imai , K. , Itoh , T. , Taniguchi , M. , Miura , K. and Kurosawa , Y.Convenient plasmid vectors for construction of chimeric mouse/human antibodies . FEBS Lett. , 244 , 301 – 306 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Hamada , H. , Okochi , E. , Oh‐hara , T. and Tsuruo , T.Purification of the Mr 22,000 calcium‐binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies . Cancer Res. , 48 , 3173 – 3178 ( 1988. ). [PubMed] [Google Scholar]
  • 27. ) Hamada , H. , Maezawa , K. and Tsuruo , T.Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16 . Nucleic Acids Res. , 18 , 1900 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Gubler , U. and Hoffman , B. J.simple and very efficient method for generating cDNA libraries . Gene , 25 , 263 – 269 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Benton , W. D. and Davis , R. W.Screening λgt recombinant clones by hybridization to single plaques in situ . Science , 196 , 180 – 182 ( 1977. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Maniatis , T. , Fritsch , E. F. and Sambrook , J. “ Molecular Cloning: A Laboratory Manual ” ( 1982. ). Cold Spring Harbor Laboratory; , New York . [Google Scholar]
  • 31. ) Potter , H. , Weir , L. and Leder , P.Enhancer‐dependent expression of human κ immunoglobulin genes introduced into mouse pre‐B lymphocytes by electroporation . Proc. Natl. Acad. Sci. USA , 81 , 7161 – 7165 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. ) Toneguzzo , F. , Hayday , A. C. and Keating , A.Electric field‐mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells . Mol. Cell. Biol. , 6 , 703 – 706 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. ) Underwood , P. A.Removal of bovine immunoglobulin from serum in hybridoma culture media using protein A . Methods Enzymol. , 121 , 301 – 306 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Goding , J. W. “ Monoclonal Antibodies: Principles and Practice ” ( 1983. ). Academic Press; , New York . [Google Scholar]
  • 35. ) Hamada , H. and Tsuruo , T.Determination of membrane antigens by a covalent crosslinking method with monoclonal antibodies . Anal. Biochem. , 160 , 483 – 488 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Horwitz , A. H. , Chang , C. P. , Better , M. , Hellstrom , K. E. and Robinson , R. R.Secretion of functional antibody and Fab fragment from yeast cells . Proc. Natl. Acad. Sci. USA , 85 , 8678 – 8682 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. ) Laemmli , U. K.Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature , 227 , 680 – 685 ( 1970. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Hamada , H. and Tsuruo , T.Growth inhibiton of multi‐drug‐resistant cells by monoclonal antibodies against P‐glycoprotein . In “ Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells ,” ed. Roninson I. B. , pp. 373 – 391 ( 1991. ). Plenum Publishing Corp. , New York . [Google Scholar]
  • 39. ) Brüggemann , M. , Williams , G. T. , Bindon , C. I. , Clark , M. R. , Walker , M. R. , Jefferis , R. , Waldmann , H. and Neuberger , M. S.Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies . J. Exp. Med. , 166 , 1351 – 1361 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. ) Steplewski , Z. , Sun , L. K. , Shearman , C. W. , Ghrayeb , J. , Daddona , P. and Koprowski , H.Biological activity of human‐mouse IgG1, IgG2, IgG3 and IgG4 chimeric monoclonal antibodies with antitumor specificity . Proc. Natl. Acad. Sci. USA , 85 , 4852 – 4856 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. ) LoBuglio , A. F. , Wheeler , R. H. , Trang , J. , Haynes , A. , Rogers , K. , Harvey , E. B. , Sun , L. , Ghrayeb , J. and Khazaeli , M. B.Mouse/human chimeric monoclonal antibody in man: kinetics and immune response . Proc. Natl. Acad. Sci. USA , 86 , 4220 – 4224 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. ) Knox , S. J. , Levy , R. , Hodgkinson , S. , Bell , R. , Brown , S. , Wood , G. S. , Hoppe , R. , Abel , E. A. , Steinman , L. , Berger , R. G. , Gaiser , C. , Young , G. , Bindl , J. , Hanham , A. and Reichert , T.Observations on the effect of chimeric anti‐CD4 monoclonal antibody in patients with mycosis fungoides . Blood , 77 , 20 – 30 ( 1991. ). [PubMed] [Google Scholar]
  • 43. ) Thiebaut , F. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. , Pastan , I. and Willingham , M.C., Cellular localization of the multidrug‐resistance gene product P‐glycoprotein in normal human tissues . Proc. Natl. Acad. Sci. USA , 84 , 7735 – 7738 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. ) Sugawara , I. , Nakahama , M. , Hamada , H. , Tsuruo , T. and Mori , S.Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000–180,000 P‐glycoprotein . Cancer Res. , 48 , 4611 – 4614 ( 1988. ). [PubMed] [Google Scholar]
  • 45. ) Cordon‐Cardo , C. , O'Brien , J. P. , Casals , D. , Rittman‐Grauer , L. , Biedler , J. L. , Melamed , M. R. and Bertino , J. R.Multidrug‐resistance gene (P‐glycoprotein) is expressed by endothelial cells at blood‐brain barrier sites . Proc. Natl. Acad. Sci. USA , 86 , 695 – 698 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. ) Thiebaut , F. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. , Pastan , I. and Willingham , M. C.Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein . J. Histochem. Cytochem. , 37 , 159 – 164 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 47. ) Galski , H. , Sullivan , M. , Willingham , M. C. , Chin , K. , Gottesman , M. M. , Pastan , I. and Merlino , G. T.Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin‐induced leukopenia . Mol. Cell. Biol. , 9 , 4357 – 4363 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. ) Mickisch , G. H. , Merlino , G. T. , Galski , H. , Gottesman , M. M. and Pastan , I.Transgenic mice that express the human multidrug‐resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance . Proc. Natl. Acad. Sci. USA , 88 , 547 – 551 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. ) Riechmann , L. , Clark , M. , Waldmann , H. and Winter , G.Reshaping human antibodies for therapy . Nature , 332 , 323 – 327 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 50. ) Queen , C. , Schneider , W. P. , Selick , H. E. , Payne , P. W. , Landolfi , N. F. , Duncan , J. F. , Avdalovic , N. M. , Levitt , M. , Junghans , R. P. and Waldmann , T. A.A humanized antibody that binds to the interleukin 2 receptor . Proc. Natl. Acad. Sci. USA , 86 , 10029 – 10033 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. ) Co , M. S. , Deschamps , M. , Whitley , R. J. and Queen , C.Humanized antibodies for antiviral therapy . Proc. Natl. Acad. Sci. USA , 88 , 2869 – 2873 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. ) Gorman , S. D. , Clark , M. R. , Routledge , E. G. , Cobbold , S. P. and Waldman , H.Reshaping a therapeutic CD4 antibody . Proc. Natl. Acad. Sci. USA , 88 , 4181 – 4185 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES